Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Current Leases (2023 - 2025)

CG Oncology (CGON) has disclosed Current Leases for 3 consecutive years, with $915000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 391.94% year-over-year to $915000.0, compared with a TTM value of $915000.0 through Dec 2025, up 391.94%, and an annual FY2025 reading of $915000.0, up 391.94% over the prior year.
  • Current Leases was $915000.0 for Q4 2025 at CG Oncology, roughly flat from $912000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $915000.0 in Q4 2025 and bottomed at $186000.0 in Q4 2024.
  • Average Current Leases over 3 years is $383888.9, with a median of $237000.0 recorded in 2024.
  • The sharpest move saw Current Leases decreased 14.29% in 2024, then skyrocketed 391.94% in 2025.
  • Year by year, Current Leases stood at $217000.0 in 2023, then dropped by 14.29% to $186000.0 in 2024, then surged by 391.94% to $915000.0 in 2025.
  • Business Quant data shows Current Leases for CGON at $915000.0 in Q4 2025, $912000.0 in Q3 2025, and $288000.0 in Q2 2025.